Modeling the effect of reduced traffic due to COVID-19 measures on air quality using a chemical transport model: impacts on the Po Valley and the Swiss Plateau regions.

The spread of COVID-19 has posed serious challenges for the global communities. To reduce the circulation of the infection, governmental bodies have imposed different lockdown measures at various levels of complexity and duration. As a result, a substantial reduction in mobility might have important, yet unknown, implications for air quality. In this study, we applied the Comprehensive Air quality Model with eXtensions (CAMx) to investigate potential changes in air quality and its chemical composition over northern Italy and Switzerland during periods when lockdown measures were enforced. Our results indicated that lockdown measures reduced nitrogen dioxide (NO2) air concentrations by up to 46% and 25% in the Po Valley and Swiss Plateau regions, respectively, whereas fine particulate matter (PM2.5) air concentrations were reduced only by up to 10% and 6%. This highlights the importance of other emission categories other than traffic for the total PM2.5 levels. The analysis of the PM2.5 components indicated that elemental carbon (EC) and particulate nitrate (NO3 -) were the species most affected by the lockdown measures, whereas a mild increase in the secondary organic aerosol (SOA) concentrations occurred in the Po Valley, and specifically over the metropolitan area of Milan. Our results indicated that an increase in the oxidation capacity of the atmosphere, i.e. in the ˙OH and ˙NO3 radicals, was mainly responsible for the mild increase in SOA concentrations.

Emerging Investigator Series: COVID-19 lockdown effects on aerosol particle size distributions in northern Italy.

The lockdown measures implemented to curb the COVID-19 epidemic in Italy reduced human mobility dramatically, which resulted in a marked decline in traffic intensity. In this study, we present the effect of lockdown measures on several air pollutants, particle number size distribution as well as on regional new particle formation (NPF) frequency in the Po Valley (northern Italy). The results show that during the lockdown period, concentrations of nitrogen dioxide (NO2), nitric oxide (NO), benzene (C6H6), and toluene (C7H8) decreased, while ozone (O3) concentrations mildly increased as compared to the corresponding period in 2016-2019. Unlike gaseous pollutants, particulate matter mass concentrations (PM2.5 and PM10) showed no significant changes. The impact of lockdown measures on particle number size distributions were also quite limited. During the lockdown period, the number concentrations of 10-25 and 25-50 nm primary particles were reduced by 66% and 34%, respectively, at the regional background site (Ispra) but surprisingly there was no difference during and after lockdown at the urban background site (Modena). Conversely, the NPF frequency was exceptionally high, 70%, in Modena during the lockdown as compared to values (22-26%) observed for the same period in 2006 and 2009, while NPF frequency in Ispra only slightly increased compared to the same period in 2016-2019. The particle growth rates, however, were slightly lower during the lockdown at both sites compared to other periods. The study shows that a drastic decrease in traffic had little influence on particulate pollution levels in the Po Valley, suggesting that other sources and processes also have a prominent impact on particle number and particulate matter mass concentration in this region.

Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2.

The COVID-19 pandemic has been disastrous to society and effective drugs are urgently needed. The papain-like protease domain (PLpro) of SARS-CoV-2 (SCoV2) is indispensable for viral replication and represents a putative target for pharmacological intervention. In this work, we describe the development of a potent and selective SCoV2 PLpro inhibitor, 19. The inhibitor not only effectively blocks substrate cleavage and immunosuppressive function imparted by PLpro, but also markedly mitigates SCoV2 replication in human cells, with a submicromolar IC50. We further present a convenient and sensitive activity probe, 7, and complementary assays to readily evaluate SCoV2 PLpro inhibitors in vitro or in cells. In addition, we disclose the co-crystal structure of SCoV2 PLpro in complex with a prototype inhibitor, which illuminates their detailed binding mode. Overall, these findings provide promising leads and important tools for drug discovery aiming to target SCoV2 PLpro.